Seneca Growth Capital VCT

Name
Seneca Growth Capital VCT
Manager
Seneca Growth Capital VCT PLC
Type
Closed Ended Investment Company
ISIN
GB0031256109
Sector
VCT Specialist: Healthcare & Biotechnology
Launched
19/04/2002
OCF
2.24 %
3 Year Sharpe
0.18
Yield
0 %
Benchmark
FTSE AllSh TR GBP
Fund Size
£ 1.87 million
NAV
34
Gearing
120
Discount Premium
-32
The objective of Company has to date been to provide shareholders with an attractive income and capital return by investing its funds in a portfolio of unquoted and quoted UK MedTech companies which meet the relevant criteria under the VCT Rules. The Company targets well managed businesses with strong leadership, that can demonstrate established and proven concepts, and are seeking an injection of growth capital to support their continued development.
Holding %
Hallmarq Veterinary Imaging 28.59 %
Scancell Plc 22.98 %
Or Productivity 9.36 %
Fuel 3d Technologies 3.89 %
Omega Diagnostics Plc 3.82 %
Arecor 3.55 %
Insense 1.71 %
Exosect 1.69 %
Microarray 0.94 %
Name
Seneca Growth Capital VCT PLC
Address
Brackley, United Kingdom
UCITS
No
Legal Structure
Closed Ended Investment Company

Managers

Not Disclosed
Joined 07/30/2007

Data provided by Morningstar.

The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Money Observer and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.

This information is sourced from our partner Morningstar. We believe the data to be correct however you should take care in using any information.

You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.